Qube Research & Technologies (QRT)
STRO icon

Qube Research & Technologies (QRT)’s Sutro Biopharma STRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
+106,610
New +$3.32M ﹤0.01% 1806
2025
Q4 		– Sell
-6,523
Closed -$56.6K – 4067
2025
Q3 		$56.6K Sell
6,523
-5,017
-43% -$42.7K ﹤0.01% 3164
2025
Q2 		$82.4K Buy
+11,540
New +$94.4K ﹤0.01% 3068
2024
Q4 		– Sell
-6,890
Closed -$238K – 3800
2024
Q3 		$238K Sell
6,890
-171
-2% -$6.7K ﹤0.01% 2521
2024
Q2 		$207K Buy
+7,061
New +$279K ﹤0.01% 2416
2023
Q4 		– Sell
-495
Closed -$17.2K – 4712
2023
Q3 		$17.2K Buy
+495
New +$21.6K ﹤0.01% 3193
2023
Q2 		– Sell
-3,963
Closed -$183K – 2989
2023
Q1 		$183K Buy
+3,963
New +$251K ﹤0.01% 1961
2022
Q3 		– Sell
-2,930
Closed -$153K – 3009
2022
Q2 		$153K Buy
+2,930
New +$164K ﹤0.01% 1803
2022
Q1 		– Sell
-1,009
Closed -$150K – 2983
2021
Q4 		$150K Buy
+1,009
New +$181K ﹤0.01% 2051
2021
Q3 		– Sell
-1,534
Closed -$285K – 2747
2021
Q2 		$285K Buy
1,534
+389
+34% +$76.1K ﹤0.01% 1608
2021
Q1 		$261K Buy
+1,145
New +$272K ﹤0.01% 1526

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STRO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Sutro Biopharma (STRO) in Q2 2026: 106,610 shares worth $3.54M. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in STRO as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in STRO in Q1 2021 and has held it in 11 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 106,610 shares of Sutro Biopharma worth $3.54M as of Q2 2026.
  • Sutro Biopharma was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1806 holding.
  • Qube Research & Technologies (QRT) first reported a position in Sutro Biopharma in Q1 2021 and has held it in 11 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.